Adjuvants added to a vaccine boost the immune response to produce more antibodies and longer-lasting immunity. Chemically, they typically consist of aluminium salts, which are said to pose a risk to infants. This new adjuvant platform consists of silaffin silica particles, is free of aluminium, improves shelf-life and reduces necessity for cold chain . . .

For more information: Register here